mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.83 |
0.0002 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.24 |
0.0002 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.54 |
0.0002 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.5 |
0.0002 |